• 14962 Citations
  • 60 Scopus h-Index
19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2017

EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: Evaluation of patient cohort and literature review

Mehner, C., Oberg, A. L., Goergen, K. M., Kalli, K. R., Maurer, M. J., Nassar, A., Goode, E. L., Keeney, G., Jatoi, A., Radisky, D. C. & Radisky, E. S., May 1 2017, In : Genes and Cancer. 8, 5-6, p. 589-599 11 p.

Research output: Contribution to journalReview article

11 Scopus citations
2016

Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer

Jatoi, A., Vierkant, R. A., Hawthorne, K. M., Block, M. S., Ramus, S. J., Larson, N. B., Fridley, B. L. & Goode, E. L., Feb 1 2016, In : Oncology (Switzerland). 90, 2, p. 59-68 10 p.

Research output: Contribution to journalReview article

6 Scopus citations

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

KConFab investigators, Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, Consortium of Modifiers of BRCA1 and BRCA2, Australian Ovarian Cancer Study Group, Australian Ovarian Cancer Study Group, Australian Ovarian Cancer Study Group & GEMO Study Collaborators, May 1 2016, In : Gynecologic oncology. 141, 2, p. 386-401 16 p.

Research output: Contribution to journalReview article

8 Scopus citations
2014

A review of the application of inflammatory biomarkers in epidemiologic cancer research

Brenner, D. R., Scherer, D., Muir, K., Schildkraut, J., Boffetta, P., Spitz, M. R., Marchand, L. L., Chan, A. T., Goode, E. L., Ulrich, C. M. & Hung, R. J., Sep 1 2014, In : Cancer Epidemiology Biomarkers and Prevention. 23, 9, p. 1729-1751 23 p.

Research output: Contribution to journalReview article

51 Scopus citations
2011

Immunity and immune suppression in human ovarian cancer

Preston, C. C., Goode, E. L., Hartmann, L. C., Kalli, K. R. & Knutson, K. L., Apr 1 2011, In : Immunotherapy. 3, 4, p. 539-556 18 p.

Research output: Contribution to journalReview article

66 Scopus citations
2009

Role of genetic polymorphisms and ovarian cancer susceptibility

Fasching, P. A., Gayther, S., Pearce, L., Schildkraut, J. M., Goode, E., Thiel, F., Chenevix-Trench, G., Chang-Claude, J., Wang-Gohrke, S., Ramus, S., Pharoah, P. & Berchuck, A., Apr 1 2009, In : Molecular Oncology. 3, 2, p. 171-181 11 p.

Research output: Contribution to journalReview article

65 Scopus citations
2005

Polymorphic variation in hOGG1 and risk of cancer: A review of the functional and epidemiologic literature

Weiss, J. M., Goode, E. L., Ladiges, W. C. & Ulrich, C. M., Mar 1 2005, In : Molecular Carcinogenesis. 42, 3, p. 127-141 15 p.

Research output: Contribution to journalReview article

212 Scopus citations
2002

Polymorphisms in DNA repair genes and associations with cancer risk

Goode, E. L., Ulrich, C. M. & Potter, J. D., Dec 1 2002, In : Cancer Epidemiology Biomarkers and Prevention. 11, 12, p. 1513-1530 18 p.

Research output: Contribution to journalReview article

1070 Scopus citations
1999

Confirmation of prostate cancer susceptibility genes using high-risk families.

Jarvik, G. P., Stanford, J. L., Goode, E. L., McIndoe, R., Kolb, S., Gibbs, M., Hood, L. & Ostrander, E. A., 1999, In : Journal of the National Cancer Institute. Monographs. 26, p. 81-87 7 p.

Research output: Contribution to journalReview article

Open Access
9 Scopus citations